186 related articles for article (PubMed ID: 34713497)
1. Identification of biomarkers related to glycolysis with weighted gene co-expression network analysis in oral squamous cell carcinoma.
Zhou X; Xue D; Qiu J
Head Neck; 2022 Jan; 44(1):89-103. PubMed ID: 34713497
[TBL] [Abstract][Full Text] [Related]
2. Identification of Co-Expression Modules and Genes Associated With Tumor Progression in Oral Squamous Cell Carcinoma.
Fang Z; Wang F; Zhang M; Huang H; Lin Z
Pathol Oncol Res; 2022; 28():1610481. PubMed ID: 36052378
[TBL] [Abstract][Full Text] [Related]
3. Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma.
Ge Y; Li W; Ni Q; He Y; Chu J; Wei P
Med Sci Monit; 2019 Sep; 25():7272-7288. PubMed ID: 31562292
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of genes associated with copper death in oral squamous cell carcinoma based on machine learning and weighted gene co-expression network analysis.
Zhang M; Li Q; Zhang W; Yang Y; Gu J; Dong Q
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101561. PubMed ID: 37451513
[TBL] [Abstract][Full Text] [Related]
5. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
6. A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes.
Liu Y; Wang T; Li R
BMC Oral Health; 2022 Aug; 22(1):324. PubMed ID: 35922788
[TBL] [Abstract][Full Text] [Related]
7. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.
Jin Y; Qin X
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707
[TBL] [Abstract][Full Text] [Related]
8. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
Zhang G; Zhao X; Liu W
Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
[TBL] [Abstract][Full Text] [Related]
9. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
[TBL] [Abstract][Full Text] [Related]
10. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
11. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
Hu X; Sun G; Shi Z; Ni H; Jiang S
PeerJ; 2020; 8():e8505. PubMed ID: 32117620
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma.
Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q
Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767
[TBL] [Abstract][Full Text] [Related]
14. Identification of hub methylated-CpG sites and associated genes in oral squamous cell carcinoma.
Dai Y; Lv Q; Qi T; Qu J; Ni H; Liao Y; Liu P; Qu Q
Cancer Med; 2020 May; 9(9):3174-3187. PubMed ID: 32155325
[TBL] [Abstract][Full Text] [Related]
15. Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
Wang J; Wang Y; Kong F; Han R; Song W; Chen D; Bu L; Wang S; Yue J; Ma L
J Cell Physiol; 2020 Mar; 235(3):3056-3068. PubMed ID: 31538341
[TBL] [Abstract][Full Text] [Related]
16. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
17. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
18. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
Zhang C; Cai Q; Ke J
Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
[TBL] [Abstract][Full Text] [Related]
19. Gold Nanostars Combined with the Searched Antibody for Targeted Oral Squamous Cell Carcinoma Therapy.
Cai L; Wang Y; Peng X; Li W; Yuan Y; Tao X; Yao X; Lv R
ACS Biomater Sci Eng; 2022 Jun; 8(6):2664-2675. PubMed ID: 35603744
[TBL] [Abstract][Full Text] [Related]
20. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
